Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning…
Pharmaceuticals, Biotechnology and Life Sciences
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning…
The waste carbon-to-ethanol facility will transform Henan Energy Group’s on-site waste gases into 50,000 tons of ethanol per year Sylonto…
Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of…
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce developmentMonrovia,…
MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage…
MELBOURNE, Australia, Nov. 19, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces…
INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Pliant Therapeutics,…
CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated…
FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — TrueBinding, Inc., a clinical-stage biotherapeutics company focused on pioneering the development…
– Met primary endpoint with LDL-C mean reduction versus placebo of 36.3% at day 84 and 41.5% at day 365…